Isaure R.
- Country
- France
- Department
- Radiotherapy
Research Overview
Data & Insights
Has run more than one trial at 0 of 31 partner sites.
Specializations
Radiotherapy and Local Oncology
Clinical research activity includes radiotherapy-based treatment strategies for locally advanced head and neck squamous cell carcinoma, anal squamous cell carcinoma, cervical cancer, and rectal cancer, with attention to organ preservation and local disease control.
- Head and neck squamous cell carcinoma
- Anal squamous cell carcinoma
- Cervical cancer
- Rectal cancer
Work also extends to reirradiation and combined-modality approaches in previously treated pelvic and head and neck malignancies.
Breast Cancer and Endocrine-Driven Disease
The investigator is involved in studies across breast cancer, especially HER2-negative, hormone receptor-positive, HER2-positive, and triple-negative breast cancer, with interest in early, locally advanced, metastatic, and treatment-resistant settings.
- HER2-negative breast cancer
- Hormone receptor-positive breast cancer
- HER2-positive breast cancer
- Triple-negative breast cancer
Research also includes endocrine therapy resistance, CDK4/6 inhibitor-exposed disease, and biomarker-defined therapeutic selection.
Ovarian, Endometrial, and Other Gynecological Cancers
Clinical trial involvement covers ovarian cancer, endometrial carcinoma, cervical cancer, vulvar cancer, and related gynecological malignancies, including recurrent, metastatic, and platinum-resistant disease.
- Ovarian cancer
- Endometrial carcinoma
- Cervical cancer
- Vulvar cancer
Therapeutic interests include PARP inhibitor-based treatment, immunotherapy, and strategies for biomarker-selected gynecologic tumors.
Sarcoma and Rare Tumors
Research activity includes soft tissue sarcoma, osteosarcoma, chondrosarcoma, gastrointestinal stromal tumor, and other rare solid tumors, with emphasis on difficult-to-treat and relapsed disease.
- Soft tissue sarcoma
- Osteosarcoma
- Chondrosarcoma
- Gastrointestinal stromal tumor
Interest also extends to molecularly targeted therapy and immune-based treatment in selected rare tumor populations.
Head and Neck, Thoracic, and Genitourinary Cancers
The investigator contributes to trials in non-small cell lung cancer, small cell lung carcinoma, prostate cancer, urothelial carcinoma, and thymic carcinoma, reflecting a broad interest in advanced solid tumors.
- Non-small cell lung cancer
- Prostate cancer
- Urothelial carcinoma
- Thymic carcinoma
Therapeutic domains include immunotherapy, targeted therapy, and precision approaches for biomarker-defined advanced disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.